Hims & Hers officer proposes $95.6K share sale
The proposed sale is listed through Fidelity Brokerage Services LLC, with an approximate sale date of October 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. officer Soleil Boughton reported a proposed sale of 3,462 Class A shares with an aggregate market value of $95,551.20. The notice also lists five prior Class A sales by Boughton, dated August 19, September 2, September 16, September 30 and October 14, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Rule 144 regulatory
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior HIMS stock sales did Soleil Boughton report?
When and through which broker is the proposed HIMS sale listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.